Study on the Effects of Human Albumin Solution and Electrolyte Drug Combination for Fluid Therapy in Patients Undergoing Laparoscopic Surgery

This clinical trial is focused on studying the effects of fluid therapy during laparoscopic surgery, which is a type of surgery performed through small incisions with the help of a camera. The study will compare two different treatments: Ringer's solution, which is a mixture of electrolytes including sodium lactate solution, magnesium chloride hexahydrate, potassium chloride, sodium chloride, and calcium chloride dihydrate, and human albumin solution, a protein derived from human blood. These treatments are used to optimize plasma volume and maintain stable blood flow during surgery.

The purpose of the study is to understand how these fluids affect the body during surgery, especially when the abdomen is inflated with carbon dioxide, which is common in laparoscopic procedures. Participants will receive either Ringer's solution or human albumin solution through an intravenous infusion, which means the fluid is delivered directly into a vein. The study will observe changes in blood components like hemoglobin and albumin, as well as kidney function and fluid balance before and after surgery.

The trial aims to provide insights into the best fluid management practices during surgery to ensure patient safety and improve surgical outcomes. By comparing these two treatments, the study hopes to determine which fluid is more effective in maintaining the necessary blood volume and circulation during the surgical procedure. The findings could help guide future recommendations for fluid therapy in surgical settings.